Does a rabbit have feathers or fur? Development of a 42-item semantic memory test (SMT-42).

Semantic variant primary progressive aphasia screening semantic memory test

Journal

Journal of clinical and experimental neuropsychology
ISSN: 1744-411X
Titre abrégé: J Clin Exp Neuropsychol
Pays: England
ID NLM: 8502170

Informations de publication

Date de publication:
09 2022
Historique:
entrez: 21 10 2022
pubmed: 22 10 2022
medline: 26 10 2022
Statut: ppublish

Résumé

We present the preliminary study of the 42-item Semantic Memory Test (SMT-42), a test developed to distinguish semantic variant primary progressive aphasia (svPPA) from the other variants: logopenic (lPPA) and nonfluent/agrammatic (naPPA). The test requires the patient to retrieve the conceptual features of items belonging to different lexical categories. In the first study, we administered the French version of the SMT-42 to a population of healthy subjects and to patients with svPPA matched to a subgroup of the healthy subjects. In the second study, we administered the SMT-42 to four groups of patients (with svPPA, lPPA, naPPA and Alzheimer's disease [AD], respectively) to study its capacity to differentiate patients suffering from svPPA from the other patients. In the first study, 109 healthy subjects were included, 15 of whom were paired with 15 subjects presenting with svPPA. In the second study, designed to compare groups presenting a primary progressive aphasia variant and AD, 12 subjects with svPPA, 6 with naPPA and 9 with lPPA were included, along with 21 subjects with AD. The subjects presenting a semantic deficit were clearly distinguished from the others by their results on the SMT-42 (svPPA: mean = 30.0 (5.9); lPPA: mean = 37.8 (3.3), d = 1.5, p = 0.002; naPPA: mean = 39.8 (1.9), d = 1.89, p = 0.001; AD: mean = 38.5 (2.4), d = 1.63, p < 0.001); (svPPA: median = 31; lPPA: median = 38, U = 9, p = 0.002; naPPA: median = 40.5, U = 1.5, p = 0.001; AD: median = 39, U = 13.5, p < 0.001). The SMT-42 is simple, rapidly administered (3 minutes on average), easily scored and has good sensitivity, and it appears to be an effective tool for semantic screening in routine clinical practice.

Identifiants

pubmed: 36269845
doi: 10.1080/13803395.2022.2133088
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

514-531

Auteurs

Aurélien Mazoué (A)

Département de Neurologie, Centre Mémoire Ressource et Recherche (CMRR), CHU de Nantes, Nantes, France.

Aurélie Gaultier (A)

Direction de la recherche, Plateforme de Méthodologie et Biostatistique, CHU de Nantes, Nantes, France.

Laëtitia Rocher (L)

Département de Neurologie, Centre Mémoire Ressource et Recherche (CMRR), CHU de Nantes, Nantes, France.

Anne-Laure Deruet (AL)

Département de Neurologie, Centre Mémoire Ressource et Recherche (CMRR), CHU de Nantes, Nantes, France.

Martine Vercelletto (M)

Département de Neurologie, Centre Mémoire Ressource et Recherche (CMRR), CHU de Nantes, Nantes, France.
Inserm CIC 04, CHU de Nantes, Nantes, France.

Claire Boutoleau-Bretonnière (C)

Département de Neurologie, Centre Mémoire Ressource et Recherche (CMRR), CHU de Nantes, Nantes, France.
Inserm CIC 04, CHU de Nantes, Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH